Company Overview

Update
Headquarters:
Finans
Funding:
$145.8M
Categories:
Biotechnology
Description:
Biotie is a specialized drug development company focused on the central nervous system and inflammatory diseases.

Detailed Description

Update

Biotie is a specialized drug development company focused on central nervous system and inflammatory diseases. It has several innovative small molecule and biological drug candidates at different stages of clinical development. Biotie's products address diseases with high unmet medical need and significant market potential, including addiction and a broad range of inflammatory conditions such as rheumatoid arthritis and chronic obstructive pulmonary disease (COPD). The most advanced product, nalmefene for alcohol dependence, is currently in phase III clinical development by licensing partner H. Lundbeck A/S.

Current Team (3)

Update

Past Team (1)

Update

Funding Rounds (2) - $145.8M

Update
  • $2M / Grant

    Jul 9, 2014
  • $143.8M / Grant

    Jun 26, 2013

Board Members and Advisors (1)

Update

Acquisitions (2)

Update

Offices/Locations (1)

Update
  • Office

    Tykistökatu 6

    Finans, FI-20520

    FIN